#SVB Leerink Maintains Outperform on #Johnson &amp; Johnson $JNJ, Lowers Price Target to $160; #WellsFargo Maintains Overweight on $JNJ, Lowers Price Target to $150 #healthcare #DRUGS #drug #Manufacturing #stocks #StockMarket #stockstowatch #StocksToTrade https://t.co/5JE2nlalc3 https://t.co/dk8TgLQxp7